Oracle Stock Dips Despite Continued Strong Backlog Growth. Should Investors Buy the Stock on the Dip?

Investors continue to worry about the return Oracle will get on its AI infrastructure spending.

I Cashed Out Of Oracle For +50%, Now I'm Buying Back In (Rating Upgrade)

Oracle Corporation is re-rated as a Strong Buy after a 30% price correction, with a $330 price target for 12 months. Click ...
The Next Platform

While Oracle Will Rake In Big Bucks On AI, Profits Are Hard To Predict

This assumes that OpenAI, the big customer in that revenue backlog, can come up with the cash. Oracle is making that ...
Becker's Hospital Review

Oracle Health’s biggest moves

Oracle Health spent the first half of 2026 accelerating its push to remake healthcare technology through AI, expanding its footprint across the Department of Veterans Affairs and introducing new ...

Investors Don’t Like Oracle’s AI Spending Plans—And the Stock Is in the Red for the Year

Oracle shares plunged after the tech giant said it expects to raise billions of dollars this fiscal year to fund its AI buildout. The news overshadowed record quarterly results and a record backlog.